Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
1.420
-0.060 (-4.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Aspira Women's Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AWH stock have an average target of 4.45, with a low estimate of 3.30 and a high estimate of 5.60. The average target predicts an increase of 200.68% from the current stock price of 1.48.
Analyst Consensus: Buy
* Price targets were last updated on Apr 10, 2024.
Analyst Ratings
The average analyst rating for AWH stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $3.3 | Hold | Reiterates | $3.3 | +122.97% | Apr 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $4 → $3.3 | Hold | Maintains | $4 → $3.3 | +122.97% | Apr 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $4 | Hold | Reiterates | $4 | +170.27% | Sep 26, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $5.6 | Strong Buy | Initiates | $5.6 | +278.38% | Aug 22, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $2 → $4.5 | Hold | Maintains | $2 → $4.5 | +204.05% | May 17, 2023 |
Financial Forecast
Revenue This Year
10.97M
from 9.15M
Increased by 19.81%
Revenue Next Year
22.77M
from 10.97M
Increased by 107.58%
EPS This Year
-1.31
from -1.81
EPS Next Year
-0.85
from -1.31
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.6M | 30.6M | 43.4M | 85.6M | 107.0M |
| Avg | 11.0M | 22.8M | 39.0M | 82.3M | 102.9M |
| Low | 10.5M | 13.7M | 35.2M | 79.9M | 99.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 26.2% | 178.6% | 90.5% | 119.6% | 30.0% |
| Avg | 19.8% | 107.6% | 71.2% | 111.2% | 25.0% |
| Low | 14.2% | 25.1% | 54.5% | 104.9% | 21.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.30 | -0.87 | -0.47 |
| Avg | -1.31 | -0.85 | -0.45 |
| Low | -1.33 | -0.83 | -0.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.